Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Small-Molecule Targeting of Musashi RNA-Binding Activity in Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 428.

https://doi.org/10.1182/blood-2018-99-118745

Published: 2018

Journal Articles

Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 1523.

https://doi.org/10.1182/blood-2018-99-112591

Published: 2018

Journal Articles

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Blood (2018) 132 (Supplement 1): 747.

https://doi.org/10.1182/blood-2018-99-119530

Published: 2018

Journal Articles

Molecular Predictors and Current Management of Minimal Residual Disease (MRD) Following Induction Chemotherapy for Acute Myeloid Leukemia (AML)

Blood (2018) 132 (Supplement 1): 292.

https://doi.org/10.1182/blood-2018-99-112938

Published: 2018

Journal Articles

Whole Genome Sequencing of Extramedullary Myeloma Autopsy Tumors Reveals a Genomic Portrait at Culmination of Clonal Convergence

Venkata D Yellapantula, Even H Rustad, Dominik Glozdik, PhD, Gunes Gundem, PhD, Jun Fan, Juan Medina, MS, Akshar Patel, BA, Minal Patel, BA, Malin Hultcrantz, MD PhD, Jonathan U. Peled, MD, Nikoletta Lendvai, MD PhD, Ola Landgren, MD PhD, Sergio Giralt, MD, Christine Iacobuzio-Donahue, Elli Papaemmanuil, PhD, Heather J. Landau, MD, Alexander M. Lesokhin, MD

Blood (2018) 132 (Supplement 1): 3169.

https://doi.org/10.1182/blood-2018-99-118740

Published: 2018

Journal Articles

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Barbara Spitzer, MD, Gunes Gundem, PhD, Noushin Farnoud, PhD, Nathan Millard, MD, Erin McGovern, BA, Minal Patel, BA, Max Levine, MS, Juan Medina, MS, Yangyu Zhou, BS, Juan E. Arango Ossa, BS, Michael Francis Walsh, MD, Ross L. Levine, MD, Irene Y. Cheung, ScD, Scott A. Armstrong, MD PhD, Nai-Kong V. Cheung, MD PhD, Elli Papaemmanuil, PhD

Blood (2018) 132 (Supplement 1): 291.

https://doi.org/10.1182/blood-2018-99-120005

Published: 2018

Journal Articles

m 6 a Regulates Differentiation State and mRNA Translation in Myeloid Leukemia

Ly P Vu, PhD, Brian F Pickering, PhD, Yuanming Cheng, PhD, Zaccara Sara, PhD, Diu Nguyen, PhD, Gerard Minuesa, PhD, Timothy Chou, BS, Arthur Chow, BS, Matthew MacKay, Christopher Famulare, MS, Minal Patel, BA, Francine Garret-Bakelman, MD PhD, Ari Melnick, MD, Martin Carroll, MD, Christopher Mason, PhD, Samie R. Jaffrey, MD PhD, Michael G. Kharas, PhD

Blood (2017) 130 (Supplement 1): 791.

https://doi.org/10.1182/blood.V130.Suppl_1.791.791

Published: 2017

Journal Articles

Molecular Profiling in Extramedullary Acute Myeloid Leukemia Reveals Distinct Subgroups Defined By Mutations in KIT and RUNX1

Aaron D Goldberg, MD, Noushin Farnoud, PhD, Cody Goldberger, Minal Patel, BA, Christopher Famulare, MS, Juan Medina, Raajit K. Rampal, MD PhD, Ross L. Levine, MD, Ellin Berman, MD, Yanming Zhang, MD, Filiz Sen, MD, Elli Papaemmanuil, PhD, Martin S. Tallman, MD

Blood (2017) 130 (Supplement 1): 2663.

https://doi.org/10.1182/blood.V130.Suppl_1.2663.2663

Published: 2017

Journal Articles

SETBP1 and NRAS Mutations Are Frequent Events in Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML) Lacking JAK-STAT Activating Mutations

Blood (2017) 130 (Supplement 1): 203.

https://doi.org/10.1182/blood.V130.Suppl_1.203.203

Published: 2017

Journal Articles

RAS Pathway Mutations Are Associated with Proliferative Features and Frequently Co-Occur with TET2 mutationsin Philadelphia Negative MPN Subtypes

Bartlomiej M Getta, MBBS, Emily C Zabor, Sean Devlin, PhD, Kristina Marie Knapp, Minal Patel, BA, Abhinita Mohanty, Marcel van den Brink, MD PhD, Maria Arcila, MD, Ross L. Levine, MD, Rapaport Franck, Raajit K. Rampal, MD, PhD

Blood (2016) 128 (22): 4269.

https://doi.org/10.1182/blood.V128.22.4269.4269

Published: 2016

Journal Articles

Clinical Relevant Alterations Identified By Comprehensive Genomic Profiling Can Potentially Improve Therapeutic Option and Change Prognosis in Hematologic Malignancies

Blood (2016) 128 (22): 5109.

https://doi.org/10.1182/blood.V128.22.5109.5109

Published: 2016

Journal Articles

Biomarkers of Cardiotoxicity Among Multiple Myeloma Patients Subsequently Treated with Proteasome Inhibitor Therapy

Nikoletta Lendvai, MDPhD, Sean Devlin, PhD, Minal Patel, BA, Kristina Marie Knapp, Daniel Ekman, Ida Grundberg, David J Chung, MDPhD, Hani Hassoun, MD, Guenther Koehne, MDPhD, Alexander M. Lesokhin, MD, Heather Landau, MD, Sergio A. Giralt, MD, Neha S Korde, MD, Ola Landgren, MD PhD

Blood (2015) 126 (23): 4257.

https://doi.org/10.1182/blood.V126.23.4257.4257

Published: 2015

Journal Articles

Targeted Sequencing Reveals a Relationship Between Mutational Burden and Clinical Phenotype in MPNs

Bartlomiej Getta, MBBS,, Franck Rapaport, PhD, Sean Devlin, PhD, Chen Zhao, MD, Kristina Marie Knapp, Minal Patel, BA, Abhinita Mohanty, Marcel Van Den Brink, MD PhD, Ross L. Levine, MD, Maria Arcila, MD, Raajit K. Rampal, MD, PhD

Blood (2015) 126 (23): 4061.

https://doi.org/10.1182/blood.V126.23.4061.4061

Published: 2015

Journal Articles

High-Depth, Targeted, Next Generation Sequencing Identifies Novel Genetic Alterations in Cutaneous T-Cell Lymphoma

Kimon V. Argyropoulos, MD, Steven M Horwitz, MD, Franck Rapaport, PhD, Enrico Velardi, PhD, Patricia Myskowski, MD, Christiane Querfeld, Melissa Pulitzer, MD, Ahmet Dogan, MD PhD, Meighan Gallagher, MA, Nicholas D. Socci, PhD, Ross L. Levine, MD, Minal Patel, BA, Natasha Galasso, Marcel van den Brink, MD PhD, Lia Palomba, MD

Blood (2015) 126 (23): 1485.

https://doi.org/10.1182/blood.V126.23.1485.1485

Published: 2015

NARROW

Small-Molecule Targeting of Musashi RNA-Binding Activity in Acute Myeloid Leukemia

Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Molecular Predictors and Current Management of Minimal Residual Disease (MRD) Following Induction Chemotherapy for Acute Myeloid Leukemia (AML)

Whole Genome Sequencing of Extramedullary Myeloma Autopsy Tumors Reveals a Genomic Portrait at Culmination of Clonal Convergence

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

m 6 a Regulates Differentiation State and mRNA Translation in Myeloid Leukemia

Molecular Profiling in Extramedullary Acute Myeloid Leukemia Reveals Distinct Subgroups Defined By Mutations in KIT and RUNX1

SETBP1 and NRAS Mutations Are Frequent Events in Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML) Lacking JAK-STAT Activating Mutations

RAS Pathway Mutations Are Associated with Proliferative Features and Frequently Co-Occur with TET2 mutationsin Philadelphia Negative MPN Subtypes

Clinical Relevant Alterations Identified By Comprehensive Genomic Profiling Can Potentially Improve Therapeutic Option and Change Prognosis in Hematologic Malignancies

Biomarkers of Cardiotoxicity Among Multiple Myeloma Patients Subsequently Treated with Proteasome Inhibitor Therapy

Targeted Sequencing Reveals a Relationship Between Mutational Burden and Clinical Phenotype in MPNs

High-Depth, Targeted, Next Generation Sequencing Identifies Novel Genetic Alterations in Cutaneous T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only